WebMar 10, 2024 · On this week’s episode FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss. Why Gilead is getting flak for a positive cancer drug study; What’s gone wrong at bluebird bio; And why the FDA has been so quick to expand approval of Bristol Myers Squibb’s Opdivo for the treatment of neoadjuvant lung cancer. WebFirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss fallout from the decision by US authorities to pause roll out of Johnson & Johnson’s COVID-19 vaccine; take a look at new data for an investigational treatment being developed for essential tremor by Biogen and Sage Therapeutics; shed light on results from a physician ...
Anna Bratulic’s Profile FirstWord Pharma, FirstWord …
WebFirstWord Pharma is a trusted news and analysis service that keeps pharmaceutical professionals up-to-date with the latest industry news and intelligence from across the globe. WebPharmaceutical. Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date 2005. Operating Status Active. Company Type For Profit. Contact Email … philipp striedl google scholar
FirstWord Pharma LinkedIn
WebApr 4, 2024 · Physician Views Results: Are pharma sales reps meeting doctors’ needs? Physician Views Poll Results. By: Simon King. Ref: Physician Views Desk. Published: 04/04/2024. Findings from FirstWord's 209-physician poll suggest sales reps are on the right track when it comes to striking a balance between virtual and in-person engagement. WebFirstWord is an innovative industry intelligence leader serving tens of thousands of pharmaceutical professionals worldwide. FirstWord has your business needs covered. … WebFirstWord’s products and services are designed to help you gain a competitive edge by making key decisions with speed and confidence. FirstWord HealthTech PLUS and Pharma PLUS deliver up-to-the-minute personalised and comprehensive news, insight, analysis, and physician views of importance to your products and company. trustcon gowork